Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00.
The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association of the Pharmaceutical Industry (LIF), will explore the ways we can rethink the Alzheimer’s care pathway, particularly in the Swedish healthcare context.
Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden
The virtual event follows the launch of the Rethinking Alzheimer’s Disease White Paper: Detection & Diagnosis, looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment – MCI – stage) and what new care pathways would need to be implemented to reach out to patients at that stage. Furthermore, with disease modifying treatments targeting patients with MCI potentially coming to market in the near future, it is important to see how prepared healthcare systems are to provide these new treatments.
You can look forward to opening remarks from Prof. Suzanne Dickson (President, European Brain Council) and a keynote speech on daily life living with Alzheimer’s disease from a patient perspective.
The keynote will be followed by a panel discussion and Q&A From detection and diagnosis to innovative treatment and care, moderated by Joakim Ramsberg (Head of Science and Society, Swedish Brain Foundation). The panel will highlight the current challenges in Sweden with respect to Alzheimer’s disease early detection and diagnosis. The speakers will share perspectives on what can be done in Sweden to ensure people living with Alzheimer’s can get access to a timely, accurate diagnosis.
The second keynote address Rethinking the Alzheimer’s care pathway in Sweden will emphasise the importance of greater education and awareness that can support detection and diagnosis of Alzheimer’s in Sweden.
The event will conclude with a panel discussion and Q&A Healthcare system transformation: scaling up health systems’ readiness, which will explore what actions can be taken now to prepare health systems to provide more timely, accurate AD diagnosis.